Joyce Joseph G, Abeygunawardana Chitrananda, Xu Qiuwei, Cook James C, Hepler Robert, Przysiecki Craig T, Grimm Karen M, Roper Keith, Ip Charlotte C Yu, Cope Leslie, Montgomery Donna, Chang Mason, Campie Sherilyn, Brown Martha, McNeely Tessie B, Zorman Julie, Maira-Litrán Tomas, Pier Gerald B, Keller Paul M, Jansen Kathrin U, Mark George E
Departments of Virus and Cell Biology, Merck Research Laboratories, WP16-107, P.O. Box 4, West Point, PA 19486, USA.
Carbohydr Res. 2003 Apr 22;338(9):903-22. doi: 10.1016/s0008-6215(03)00045-4.
Colonization of implanted medical devices by coagulase-negative staphylococci such as Staphylococcus epidermidis is mediated by the bacterial polysaccharide intercellular adhesin (PIA), a polymer of beta-(1-->6)-linked glucosamine substituted with N-acetyl and O-succinyl constituents. The icaADBC locus containing the biosynthetic genes for production of PIA has been identified in both S. epidermidis and S. aureus. Whereas it is clear that PIA is a constituent that contributes to the virulence of S. epidermidis, it is less clear what role PIA plays in infection with S. aureus. Recently, identification of a novel polysaccharide antigen from S. aureus termed poly N-succinyl beta-(1-->6)-glucosamine (PNSG) has been reported. This polymer was composed of the same glycan backbone as PIA but was reported to contain a high proportion of N-succinylation rather than acetylation. We have isolated a glucosamine-containing exopolysaccharide from the constitutive over-producing MN8m strain of S. aureus in order to prepare polysaccharide-protein conjugate vaccines. In this report we demonstrate that MN8m produced a high-molecular-weight (>300,000 Da) polymer of beta-(1-->6)-linked glucosamine containing 45-60% N-acetyl, and a small amount of O-succinyl (approx 10% mole ratio to monosaccharide units). By detailed NMR analyses of polysaccharide preparations, we show that the previous identification of N-succinyl was an analytical artifact. The exopolysaccharide we have isolated is active in in vitro hemagglutination assays and is immunogenic in mice when coupled to a protein carrier. We therefore conclude that S. aureus strain MN8m produces a polymer that is chemically and biologically closely related to the PIA produced by S. epidermidis.
凝固酶阴性葡萄球菌(如表皮葡萄球菌)对植入式医疗设备的定植是由细菌多糖细胞间黏附素(PIA)介导的,PIA是一种β-(1→6)-连接的葡糖胺聚合物,被N-乙酰基和O-琥珀酰基取代。在表皮葡萄球菌和金黄色葡萄球菌中均已鉴定出包含PIA生物合成基因的icaADBC基因座。虽然很明显PIA是一种有助于表皮葡萄球菌毒力的成分,但PIA在金黄色葡萄球菌感染中起什么作用尚不清楚。最近,有报道称从金黄色葡萄球菌中鉴定出一种新型多糖抗原,称为聚N-琥珀酰基β-(1→6)-葡糖胺(PNSG)。这种聚合物与PIA具有相同的聚糖主链,但据报道含有高比例的N-琥珀酰化而非乙酰化。我们从组成型高产金黄色葡萄球菌MN8m菌株中分离出一种含葡糖胺的胞外多糖,以制备多糖-蛋白结合疫苗。在本报告中,我们证明MN8m产生了一种高分子量(>300,000 Da)的β-(1→6)-连接的葡糖胺聚合物,其中含有45-60%的N-乙酰基和少量的O-琥珀酰基(与单糖单元的摩尔比约为10%)。通过对多糖制剂的详细核磁共振分析,我们表明先前对N-琥珀酰基的鉴定是一种分析假象。我们分离出的胞外多糖在体外血凝试验中具有活性,与蛋白质载体偶联后在小鼠中具有免疫原性。因此,我们得出结论,金黄色葡萄球菌MN8m菌株产生的聚合物在化学和生物学上与表皮葡萄球菌产生的PIA密切相关。